MARKET NEWS

CureVac´s Optimized mRNA Platform Provides Positive PreClinical Results at Low Dose for COVID-19 Vaccine Candidate
Almac Discovery Enters Into Licensing Agreement for the Development & Commercialization of ALM301 
Cue Biopharma Announces Strategic Research Collaboration 
Triphase Accelerator & Catalent Announce Interim Results of a Dose Escalation Phase 1 Clinical Trial
ChemoCentryx & VFMCRP Announce Topline Data from Phase 2 LUMINA-1 Trial 
Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial

  FEATURED EDITORIAL

  COMPANY PROFILE

The Health business of Lubrizol Life Science (LLS Health) partners with customers to speed innovative differentiated pharmaceutical products and medical devices to market. Our team provides multifunctional polymers and excipients, as well as product design, development, and manufacturing services. LLS Health offers high-quality development and production of added value nutraceutical ingredients, providing nutritional and technical solutions for clients’ final products brands in the functional foods and dietary supplements industries. Click here for more.

  EXCLUSIVE ONLINE CONTENT

CanSino Biologics & Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine

CanSino Biologics & Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine

CanSino Biologics Inc. and Precision NanoSystems (PNI) recently announced a co-development agreement of a mRNA lipid nanoparticle (mRNA-LNP) vaccine against COVID-19. The parties will…

MD Anderson & Innovent Biologics Announce Strategic Rare Cancer Development Collaboration 

MD Anderson & Innovent Biologics Announce Strategic Rare Cancer Development Collaboration 

The University of Texas MD Anderson Cancer Center and Innovent Biologics, Inc. recently announced a strategic collaboration agreement to co-develop TYVYT (sintilimab injection), Innovent’s anti-PD-1 monoclonal…

Taconic Biosciences Launches Rapid Restart Program

Taconic Biosciences Launches Rapid Restart Program

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, recently announced the successful implementation of its Rapid Restart program….

COVID-19’s Effect Will Boost Infectious Disease Drug Approvals & Present Opportunities to CMOs

COVID-19’s Effect Will Boost Infectious Disease Drug Approvals & Present Opportunities to CMOs

In response to the global pandemic, biopharma companies have put a renewed emphasis on finding treatments for infectious diseases, including COVID-19 and other infectious diseases overall…..

Akers Biosciences & Premas Biotech Announce Successful Completion of COVID-19 Vaccine Prototype & Obtained First Images of VLP

Akers Biosciences & Premas Biotech Announce Successful Completion of COVID-19 Vaccine Prototype & Obtained First Images of VLP

Akers Biosciences, Inc. recently announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

June 3 – Capsules
June 10 – Injection Devices